The company’s $8 million settlement in Oct. 2010 with the New Jersey U.S. attorney’s office. The settlement was paid to resolve government allegations that the company had used consulting arrangements with physicians as a way to pay them for hip and knee implant purchases.
In conjunction with the settlement, Wright Medical entered into a deferred prosecution agreement, under which the company it is obligated to a five-year corporate integrity agreement with HHS, according to a company news release.
Meanwhile, Wright Medical’s Board of Directors has appointed Chairman David D. Stevens as interim president and CEO, effective immediately. Mr. Stevens will remain chairman of the board during this time but will only serve as the interim leader until a permanent replacement is found, according to a company news release.
Read the regulatory filing from Wright Medical Group.
Read other coverage about Wright Medical Group:
– Wright Medical Group Reports 4Q Net Sales of $138.3M, 6% Increase
– Wright Medical Group Releases EVOLVE Elbow Plating System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
